Egger Michael E, Squires Malcolm H, Kooby David A, Maithel Shishir K, Cho Clifford S, Weber Sharon M, Winslow Emily R, Martin Robert C G, McMasters Kelly M, Scoggins Charles R
Hiram C Polk Jr, MD Department of Surgery, University of Louisville, Louisville, KY.
Department of Surgery, Emory University, Atlanta, GA.
J Am Coll Surg. 2015 Apr;220(4):640-8. doi: 10.1016/j.jamcollsurg.2014.12.018. Epub 2014 Dec 20.
Hospital readmission is becoming a quality measure, despite poor understanding of the risks of readmission. This study examines readmission risk factors after major hepatectomy and develops a predictive model.
A retrospective review was performed on patients who had undergone major hepatectomy at 1 of 3 academic centers between the years 2000 and 2012. Clinicopathologic and perioperative data were analyzed for risk factors of 90-day readmission using logistic regression. A readmission risk score was developed and validated in a separate validation set to determine its predictive value.
Of 1,184 hepatectomies performed, 17.3% of patients were readmitted within 90 days. Factors associated with readmission include operative blood loss (odds ratio [OR] = 1.00; 95% CI, 1.000-1.001), any postoperative complication (OR = 4.3; 95% CI, 1.8-10.4), a major postoperative complication (OR = 5.7; 95% CI, 3.2-10.2), postoperative pulmonary embolism (OR = 12.2; 95% CI, 1.9-78.4), no postoperative blood transfusion (OR = 3.3; 95% CI, 1.7-6.2), surgical site infection (OR = 5.3; 95% CI, 2.9-10.0), and post-hepatectomy hyperbilirubinemia (OR = 1.1; 95% CI, 1.1-1.2). A scoring system based on these risk factors accurately predicted readmission in the validation cohort. A score of >20 points had a positive predictive value of 30.8% and negative predictive value of 95.6%, and a score >50 had a positive predictive value of 50.9% and negative predictive value of 87.7%. This risk score accurately stratifies readmission risk.
The risk of hospital readmission within 90 days after major hepatectomy is high and is reliably predicted with a novel scoring system.
尽管对再入院风险了解不足,但医院再入院率正成为一项质量指标。本研究调查了大肝切除术后的再入院风险因素,并建立了一个预测模型。
对2000年至2012年间在3个学术中心之一接受大肝切除术的患者进行回顾性研究。使用逻辑回归分析临床病理和围手术期数据,以确定90天再入院的风险因素。制定了再入院风险评分,并在一个单独的验证集中进行验证,以确定其预测价值。
在1184例肝切除术中,17.3%的患者在90天内再次入院。与再入院相关的因素包括手术失血量(比值比[OR]=1.00;95%可信区间,1.000 - 1.001)、任何术后并发症(OR = 4.3;95%可信区间,1.8 - 10.4)、主要术后并发症(OR = 5.7;95%可信区间,3.2 - 10.2)、术后肺栓塞(OR = 12.2;95%可信区间,1.9 - 78.4)、未进行术后输血(OR = 3.3;95%可信区间,1.7 - 6.2)、手术部位感染(OR = 5.3;95%可信区间,2.9 - 10.0)以及肝切除术后高胆红素血症(OR = 1.1;95%可信区间,1.1 - 1.2)。基于这些风险因素的评分系统能够准确预测验证队列中的再入院情况。评分>20分的阳性预测值为30.8%,阴性预测值为95.6%;评分>50分的阳性预测值为50.9%,阴性预测值为87.7%。该风险评分能够准确地对再入院风险进行分层。
大肝切除术后90天内医院再入院风险较高,且一种新的评分系统能够可靠地预测这种风险。